AptaBio Therapeutics Inc. (293780.KQ)

KRW 6500.0

(-3.56%)

Inventory Summary of AptaBio Therapeutics Inc.

  • AptaBio Therapeutics Inc.'s latest annual inventory in 2023 was - KRW , down -100.0% from previous year.
  • AptaBio Therapeutics Inc.'s latest quarterly inventory in 2024 Q2 was - KRW , up 11590.5% from previous quarter.
  • AptaBio Therapeutics Inc. reported annual inventory of 1.00 KRW in 2022, down 0.0% from previous year.
  • AptaBio Therapeutics Inc. reported annual inventory of - KRW in 2021, down 0.0% from previous year.
  • AptaBio Therapeutics Inc. reported quarterly inventory of 32.87 Million KRW for 2024 Q1, down 0.0% from previous quarter.
  • AptaBio Therapeutics Inc. reported quarterly inventory of - KRW for 2023 Q3, down 0.0% from previous quarter.

Annual Inventory Chart of AptaBio Therapeutics Inc. (2023 - 2016)

Historical Annual Inventory of AptaBio Therapeutics Inc. (2023 - 2016)

Year Inventory Inventory Growth
2023 - KRW -100.0%
2022 1.00 KRW 0.0%
2021 - KRW 0.0%
2020 - KRW 0.0%
2019 - KRW 0.0%
2018 - KRW 0.0%
2017 - KRW 0.0%
2016 - KRW 0.0%

Peer Inventory Comparison of AptaBio Therapeutics Inc.

Name Inventory Inventory Difference
HLB Pharmaceutical Co., Ltd 20.85 Billion KRW 100.0%
CMG Pharmaceutical Co., Ltd. 15.87 Billion KRW 100.0%
Celltrion Pharm, Inc. 100.42 Billion KRW 100.0%
Huons Global Co., Ltd. 121.81 Billion KRW 100.0%
DongKook Pharmaceutical Co., Ltd. 138.34 Billion KRW 100.0%
Enzychem Lifesciences Corporation 14.94 Billion KRW 100.0%
Humedix Co., Ltd. 28.62 Billion KRW 100.0%
Boditech Med Inc. 31.6 Billion KRW 100.0%
EuBiologics Co., Ltd. 13.34 Billion KRW 100.0%
FutureChem Co.,Ltd 1.37 Billion KRW 100.0%
Huons Co., Ltd. 76.59 Billion KRW 100.0%
BNC Korea Co., Ltd. 11.39 Billion KRW 100.0%